Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
| The Manila Times
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the second quarter ended June 30, 2026, on Thursday, August 6, 2026.